Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.14827 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.13153 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.13869 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.0811 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.0871 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.16832 | 6 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.14329 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.10905 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.10464 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.11909 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.11547 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.10702 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12734 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.2672 | 11 |